Was Trump given a Covid-19 treatment made by Regeneron? Yes The President's physician, Sean Conley, said in a statement that Mr Trump "remains fatigued but in good spirits" after receiving an intravenous dose of Regeneron Pharmaceuticals' dual antibody. What is Regenron's Covid-19  dual antibody? REGN-COV2 How was REGN-COV2 developed? To develop REGN-COV2, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company's VelocImmune® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19. What were the antibodies tested with? These antibodies were then tested against a replica of COVID-19 that was present in what is called a "cell line," meant to simulate the virus' effect on the human body. What cell lines were used? The effectiveness of the antibody therapy was tested by employing a fetal tissue cell line from the 1980s widely used in biomedical research, according to Regeneron Pharmaceuticals, its manufacturer. The cell line is old enough that it would fall outside restrictions on federal funding of fetal tissue research the Trump administration imposed last year, according to National Institutes of Health guidelines.
US President Donald Trump following his positive diagnosis of COVID-19, was given treatment developed from the use of fetal tissue, made by the company Regeneron.
Determine the veracity of the claim "US President Donald Trump following his positive diagnosis of COVID-19, was given treatment developed from the use of fetal tissue, made by the company Regeneron." based on the evidence in form of question-answer pairs "Was Trump given a Covid-19 treatment made by Regeneron? Yes The President's physician, Sean Conley, said in a statement that Mr Trump "remains fatigued but in good spirits" after receiving an intravenous dose of Regeneron Pharmaceuticals' dual antibody. What is Regenron's Covid-19  dual antibody? REGN-COV2 How was REGN-COV2 developed? To develop REGN-COV2, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company's VelocImmune® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19. What were the antibodies tested with? These antibodies were then tested against a replica of COVID-19 that was present in what is called a "cell line," meant to simulate the virus' effect on the human body. What cell lines were used? The effectiveness of the antibody therapy was tested by employing a fetal tissue cell line from the 1980s widely used in biomedical research, according to Regeneron Pharmaceuticals, its manufacturer. The cell line is old enough that it would fall outside restrictions on federal funding of fetal tissue research the Trump administration imposed last year, according to National Institutes of Health guidelines.".

Options: 

 - supported

 - refuted

 - not enough evidence

 - conflicting Evidence/Cherrypicking
supported
Determine the veracity of the claim "US President Donald Trump following his positive diagnosis of COVID-19, was given treatment developed from the use of fetal tissue, made by the company Regeneron." based on the evidence in form of question-answer pairs "Was Trump given a Covid-19 treatment made by Regeneron? Yes The President's physician, Sean Conley, said in a statement that Mr Trump "remains fatigued but in good spirits" after receiving an intravenous dose of Regeneron Pharmaceuticals' dual antibody. What is Regenron's Covid-19  dual antibody? REGN-COV2 How was REGN-COV2 developed? To develop REGN-COV2, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company's VelocImmune® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19. What were the antibodies tested with? These antibodies were then tested against a replica of COVID-19 that was present in what is called a "cell line," meant to simulate the virus' effect on the human body. What cell lines were used? The effectiveness of the antibody therapy was tested by employing a fetal tissue cell line from the 1980s widely used in biomedical research, according to Regeneron Pharmaceuticals, its manufacturer. The cell line is old enough that it would fall outside restrictions on federal funding of fetal tissue research the Trump administration imposed last year, according to National Institutes of Health guidelines.".

Options: 

 - supported

 - refuted

 - not enough evidence

 - conflicting Evidence/Cherrypicking
user
supported
assistant